Process for the treatment of saccharide three dimensional structures for the reactivation of recognition mechanisms among antigens and antibodies
OwnerFausto Leal Espinoza, Alberto Cornejo Lizarralde +2inventors
InventorsFausto Leal Espinoza, Alberto Cornejo Lizarralde, Jose Manuel Flores Hernandez, Victor Vargas Varela
Life of this patent
Estimating the term…
Abstract
A process of altering the three dimensional structures of saccharides involved in an infective procedure, comprising electromagnetic energy treatment to induce a change in the three dimensional structure of relevant macromolecules. The process reactivates the recognition mechanisms of antigens and antibodies.
Claims20
A process for altering the three dimensional structure of saccharides to reactivate pattern recognition mechanisms between antigens and antibodies, in a patient in need of such reactivation, comprising the following steps:
- specifically diagnosing a patient's condition;
- correlating infection mechanisms with recognition immunologic defense mechanisms,
- selecting an appropriate wavelength for treatment;
- and
- exposing the patient and thus the patient's saccharides to electromagnetic energy in the range of 100-1000 Gauss using a sequence of negative or positive phases, wherein said electromagnetic energy is simultaneously combined with photonic energy at a wavelength in the range of 3000 to 7000 .ANG. resulting in an alteration of the three dimensional structure of said saccharides.
A process for altering the three dimensional structure of saccharides, to reactivate pattern recognition mechanisms between antigens and antibodies comprising:
- correlating infection mechanisms with recognition immunologic defense mechanisms,
- selecting an appropriate wavelength for treatment, and
- exposing saccharides to electromagnetic energy in the range of 100-1000 Gauss using a sequence of negative and positive phases, simultaneously combined with photonic energy with a wavelength in the range of 3000 to 7000 .ANG..
A process for the treatment of an HIV infection in a patient in need of such treatment, comprising:
- correlating infection mechanisms with recognition immunologic defense mechanisms,
- selecting an appropriate wavelength for treatment;
- and
- exposing a patient with an HIV infection to electromagnetic energy in the range of 100-1000 Gauss using a sequence of negative and positive phases, simultaneously combined with photonic energy with a wavelength in the range of 3000 to 7000 .ANG..
Dependencies are inferred from the claim text.